10370 | 1.859 | 6.787 | 15.12 | 1.046e-38 | 1.793e-36 | 77.26 | 10370 | CITED2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | ENSG00000164442 | 602937, 614431, 614433 |
10402 | -0.4911 | 7.434 | -4.638 | 5.278e-06 | 3.514e-05 | 2.98 | 10402 | ST3GAL6 | ST3 beta-galactoside alpha-2, 3-sialyltransferase 6 | ENSG00000064225 | 607156 |
10742 | 1.216 | 5.686 | 8.298 | 3.755e-15 | 7.396e-14 | 23.54 | 10742 | RAI2 | retinoic acid induced 2 | ENSG00000131831 | 300217 |
154 | 1.505 | 8.759 | 11.79 | 1.467e-26 | 8.253e-25 | 49.51 | 154 | ADRB2 | adrenergic, beta-2-, receptor, surface | ENSG00000169252 | 109690, 600807, 601665 |
1545 | -1.239 | 8.316 | -4.325 | 2.084e-05 | 0.0001261 | 1.667 | 1545 | CYP1B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 | ENSG00000138061 | 137750, 137760, 231300, 601771, 604229 |
18 | 0.9051 | 5.019 | 8 | 2.814e-14 | 5.032e-13 | 21.56 | 18 | ABAT | 4-aminobutyrate aminotransferase | ENSG00000183044 | 137150, 613163 |
1847 | 1.989 | 8.872 | 10.12 | 7.234e-21 | 2.412e-19 | 36.53 | 1847 | DUSP5 | dual specificity phosphatase 5 | ENSG00000138166 | 603069 |
185 | 0.6249 | 4.53 | 5.981 | 6.361e-09 | 6.392e-08 | 9.48 | 185 | AGTR1 | angiotensin II receptor, type 1 | ENSG00000144891 | 106165, 145500, 267430 |
2167 | 2.76 | 7.731 | 15.75 | 4.883e-41 | 1.026e-38 | 82.59 | 2167 | FABP4 | fatty acid binding protein 4, adipocyte | ENSG00000170323 | 600434 |
22936 | 1.044 | 6.644 | 7.585 | 4.317e-13 | 6.859e-12 | 18.87 | 22936 | ELL2 | elongation factor, RNA polymerase II, 2 | ENSG00000118985 | 601874 |
23111 | -0.5844 | 7.067 | -7.333 | 2.151e-12 | 3.201e-11 | 17.3 | 23111 | SPG20 | spastic paraplegia 20 (Troyer syndrome) | ENSG00000133104 | 275900, 607111 |
23336 | -0.5729 | 8.274 | -5.552 | 6.27e-08 | 5.501e-07 | 7.257 | 23336 | SYNM | synemin, intermediate filament protein | ENSG00000182253 | 606087 |
23708 | -0.7099 | 8.51 | -8.414 | 1.701e-15 | 3.47e-14 | 24.32 | 23708 | GSPT2 | G1 to S phase transition 2 | ENSG00000189369 | 300418 |
26353 | -0.892 | 6.358 | -5.928 | 8.502e-09 | 8.388e-08 | 9.198 | 26353 | HSPB8 | heat shock 22kDa protein 8 | ENSG00000152137 | 158590, 608014, 608673 |
2766 | 1.502 | 5.497 | 17.03 | 7.611e-46 | 2.261e-43 | 93.57 | 2766 | GMPR | guanosine monophosphate reductase | ENSG00000137198 | 139265 |
2852 | -0.6483 | 5.76 | -6.468 | 4.075e-10 | 4.718e-09 | 12.16 | 2852 | GPER | G protein-coupled estrogen receptor 1 | ENSG00000164850 | 601805 |
2908 | -0.3402 | 8.562 | -4.147 | 4.404e-05 | 0.0002514 | 0.9552 | 2908 | NR3C1 | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | ENSG00000113580 | 138040 |
29969 | -1.036 | 9.175 | -11.84 | 9.9e-27 | 5.684e-25 | 49.9 | 29969 | MDFIC | MyoD family inhibitor domain containing | ENSG00000135272 | 614511 |
3570 | -0.6731 | 5.952 | -4.874 | 1.786e-06 | 1.271e-05 | 4.021 | 3570 | IL6R | interleukin 6 receptor | ENSG00000160712 | 147880 |
3800 | 1.611 | 5.756 | 13.82 | 7.129e-34 | 7.901e-32 | 66.21 | 3800 | KIF5C | kinesin family member 5C | ENSG00000168280 | 604593 |
3977 | 0.4545 | 4.27 | 5.996 | 5.859e-09 | 5.919e-08 | 9.56 | 3977 | LIFR | leukemia inhibitory factor receptor alpha | ENSG00000113594 | 151443, 601559 |
4306 | 1.085 | 6.249 | 7.199 | 5.001e-12 | 7.132e-11 | 16.47 | 4306 | NR3C2 | nuclear receptor subfamily 3, group C, member 2 | ENSG00000151623 | 177735, 600983, 605115 |
4329 | 0.737 | 7.635 | 7.913 | 5.035e-14 | 8.797e-13 | 20.99 | 4329 | ALDH6A1 | aldehyde dehydrogenase 6 family, member A1 | ENSG00000119711 | 603178, 614105 |
4616 | 0.714 | 8.351 | 4.195 | 3.613e-05 | 0.0002089 | 1.143 | 4616 | GADD45B | growth arrest and DNA-damage-inducible, beta | ENSG00000099860 | 604948 |
50810 | -0.5228 | 9.802 | -4.891 | 1.648e-06 | 1.178e-05 | 4.098 | 50810 | HDGFRP3 | hepatoma-derived growth factor, related protein 3 | ENSG00000166503 | NA |
5099 | 0.5704 | 4.742 | 6.476 | 3.899e-10 | 4.529e-09 | 12.2 | 5099 | PCDH7 | protocadherin 7 | ENSG00000169851 | 602988 |
5101 | 2.027 | 6.226 | 9.5 | 7.365e-19 | 2.025e-17 | 31.96 | 5101 | PCDH9 | protocadherin 9 | ENSG00000184226 | 603581 |
51092 | 0.629 | 8.307 | 4.66 | 4.79e-06 | 3.208e-05 | 3.073 | 51092 | SIDT2 | SID1 transmembrane family, member 2 | ENSG00000149577 | NA |
51465 | -1.412 | 7.416 | -11.75 | 2.014e-26 | 1.113e-24 | 49.2 | 51465 | UBE2J1 | ubiquitin-conjugating enzyme E2, J1, U | ENSG00000198833 | NA |
5168 | 0.3114 | 4.215 | 4.014 | 7.563e-05 | 0.0004156 | 0.4425 | 5168 | ENPP2 | ectonucleotide pyrophosphatase/phosphodiesterase 2 | ENSG00000136960 | 601060 |
5274 | 2.034 | 5.439 | 10.81 | 3.546e-23 | 1.452e-21 | 41.8 | 5274 | SERPINI1 | serpin peptidase inhibitor, clade I (neuroserpin), member 1 | ENSG00000163536 | 602445, 604218 |
54855 | 0.6712 | 4.874 | 8.033 | 2.257e-14 | 4.095e-13 | 21.78 | 54855 | FAM46C | family with sequence similarity 46, member C | ENSG00000183508 | 613952 |
55022 | 0.5422 | 5.672 | 4.141 | 4.513e-05 | 0.0002572 | 0.932 | 55022 | PID1 | phosphotyrosine interaction domain containing 1 | ENSG00000153823 | 612930 |
5523 | 0.6597 | 6.516 | 7.172 | 5.911e-12 | 8.371e-11 | 16.3 | 5523 | PPP2R3A | protein phosphatase 2, regulatory subunit B'', alpha | ENSG00000073711 | 604944 |
55323 | 0.5291 | 7.668 | 6.993 | 1.783e-11 | 2.397e-10 | 15.22 | 55323 | LARP6 | La ribonucleoprotein domain family, member 6 | ENSG00000166173 | 611300 |
5567 | 0.6303 | 9.634 | 9.655 | 2.335e-19 | 6.713e-18 | 33.1 | 5567 | PRKACB | protein kinase, cAMP-dependent, catalytic, beta | ENSG00000142875 | 176892 |
55914 | -1.27 | 8.961 | -11 | 8.109e-24 | 3.542e-22 | 43.26 | 55914 | ERBB2IP | erbb2 interacting protein | ENSG00000112851 | 606944 |
57161 | 0.5679 | 4.502 | 5.018 | 9.011e-07 | 6.691e-06 | 4.679 | 57161 | PELI2 | pellino E3 ubiquitin protein ligase family member 2 | ENSG00000139946 | NA |
5999 | 2.54 | 6.186 | 11.99 | 2.906e-27 | 1.74e-25 | 51.12 | 5999 | RGS4 | regulator of G-protein signaling 4 | ENSG00000117152 | 602516, 604906 |
64081 | -0.4301 | 5.626 | -4.333 | 2.015e-05 | 0.0001222 | 1.699 | 64081 | PBLD | phenazine biosynthesis-like protein domain containing | ENSG00000108187 | 612189 |
6456 | 0.8933 | 5.034 | 4.598 | 6.321e-06 | 4.155e-05 | 2.807 | 6456 | SH3GL2 | SH3-domain GRB2-like 2 | ENSG00000107295 | 604465 |
6594 | -0.4746 | 9.198 | -4.675 | 4.466e-06 | 3.001e-05 | 3.14 | 6594 | SMARCA1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 | ENSG00000102038 | 300012 |
79671 | -0.9538 | 6.679 | -8.238 | 5.679e-15 | 1.102e-13 | 23.13 | 79671 | NLRX1 | NLR family member X1 | ENSG00000160703 | 611947 |
79739 | 0.4934 | 5.887 | 5.23 | 3.214e-07 | 2.567e-06 | 5.674 | 79739 | TTLL7 | tubulin tyrosine ligase-like family, member 7 | ENSG00000137941 | NA |
79772 | 0.8757 | 5.649 | 4.745 | 3.241e-06 | 2.223e-05 | 3.448 | 79772 | MCTP1 | multiple C2 domains, transmembrane 1 | ENSG00000175471 | NA |
79884 | 0.5042 | 6.351 | 3.851 | 0.0001443 | 0.0007578 | -0.1677 | 79884 | MAP9 | microtubule-associated protein 9 | ENSG00000164114 | 610070 |
83604 | 0.8745 | 6.165 | 5.103 | 5.973e-07 | 4.555e-06 | 5.076 | 83604 | TMEM47 | transmembrane protein 47 | ENSG00000147027 | 300698 |
8382 | 0.5205 | 5.139 | 6.836 | 4.623e-11 | 5.943e-10 | 14.29 | 8382 | NME5 | non-metastatic cells 5, protein expressed in (nucleoside-diphosphate kinase) | ENSG00000112981 | 603575 |
8613 | -2.122 | 8.597 | -13.95 | 2.319e-34 | 2.733e-32 | 67.33 | 8613 | PPAP2B | phosphatidic acid phosphatase type 2B | ENSG00000162407 | 607125 |
956 | 0.8867 | 6.441 | 5.848 | 1.309e-08 | 1.261e-07 | 8.778 | 956 | ENTPD3 | ectonucleoside triphosphate diphosphohydrolase 3 | ENSG00000168032 | 603161 |
9783 | 0.7733 | 5.521 | 5.52 | 7.391e-08 | 6.417e-07 | 7.097 | 9783 | RIMS3 | regulating synaptic membrane exocytosis 3 | ENSG00000117016 | 611600 |
9823 | -0.3209 | 4.647 | -4.335 | 1.998e-05 | 0.0001212 | 1.707 | 9823 | ARMCX2 | armadillo repeat containing, X-linked 2 | ENSG00000184867 | 300363 |
9829 | 1.49 | 6.164 | 5.564 | 5.902e-08 | 5.192e-07 | 7.315 | 9829 | DNAJC6 | DnaJ (Hsp40) homolog, subfamily C, member 6 | ENSG00000116675 | 608375 |